NASDAQ$CCRN

Cross Country Healthcare Inc · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Briefing

Cross Country Healthcare Inc reported a net loss of $6.7 million on revenue of $274.1 million for the second quarter of 2025.

Revenue declined 19.3% year-over-year to $274.1 million due to lower volumes and bill rates in Nurse and Allied Staffing, partially offset by growth in Physician Staffing. The company posted an operating loss of $5.9 million and continued to advance the pending Aya Merger expected to close in Q4 2025. Cash and cash equivalents remained stable at $81.2 million with no borrowings under the ABL.

  • Q2 2025 revenue fell 19.3% to $274.1 million with Nurse and Allied Staffing down 23.0% and Physician Staffing up 3.0%.
  • Net loss narrowed to $6.7 million from $16.1 million in Q2 2024 as credit loss expense dropped sharply.
  • Nurse and Allied Staffing FTEs declined 16.4% while average revenue per FTE per day fell 7.7%.
  • The company incurred $6.0 million in acquisition costs related to the pending Aya Merger with no debt outstanding on the ABL.

Headline financials

Total Revenue

$274M

Previous: $340M-19.3%
EPS (adj)

-$0.20

Previous: $0.10-300.0%
Nurse and Allied Staffing FTEs

7.0K

No prior period
Nurse and Allied Staffing Rev/FTE/Day

$348.00

No prior period
Capital Expenditures

-$3.85M

Previous: -$5.06M+23.8%
Net Income

-$6.66M

Previous: -$16.1M+58.5%
Operating Income

-$5.86M

Previous: -$19.2M+69.5%
Cash & Equivalents

$81.2M

No prior period
Total Assets

$554M

No prior period

Revenue & EPS history

Cross Country Healthcare · Revenue · Quarterly

$274M

Q2 2025-19.3%vs Q2 2024
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Cross Country Healthcare · $274M total across 2 segments · Q2 2025

  • Nurse and Allied Staffing
    $224M
  • Physician Staffing
    $49.8M

Forward guidance

The pending Aya Merger is expected to close in the fourth quarter of 2025 subject to regulatory approvals and other closing conditions.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-2.7%

Avg return

Earnings day

-1.5%

Avg return

5 days after

+0.5%

Avg return

30 days after

44%

28 / 64 earnings

Positive

+24.6%

Q3 2021

Best reaction

-33.6%

Q2 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026+0.8%+0.4%+0.8%
Q4 2025+8.2%+7.9%+0.5%
Q3 2025-14.1%-7.2%-32.9%
Q1 2025+0.4%+0.8%-6.7%
Q4 2024+0.3%-6.0%-13.9%
Q3 2024+7.2%-6.1%+57.9%
Q2 2024-2.7%-8.2%-17.3%
Q1 2024-4.9%-9.0%-14.1%
Q4 2023-2.7%-0.3%+5.7%
Q3 2023-14.0%-19.0%-10.7%
Q2 2023-14.7%-14.0%-3.8%
Q1 2023+5.1%+9.9%+26.1%
Q4 2022-5.6%+3.2%-13.2%
Q3 2022-2.5%-11.3%-2.8%
Q2 2022-13.7%-14.1%-7.6%
Q1 2022-2.6%-7.1%+0.9%
Q4 2021-1.5%+6.6%+2.4%
Q3 2021+24.6%+18.0%+21.1%
Q2 2021+23.0%+14.6%+29.7%
Q1 2021+16.5%+24.0%+17.4%
Q4 2020+18.9%+24.6%+33.8%
Q3 2020-5.0%-3.0%+9.3%
Q2 2020+9.6%+4.7%+1.6%
Q1 2020-4.8%-2.0%+7.6%
Q4 2019+0.4%-12.2%-27.7%
Q3 2019+14.2%+16.9%+10.9%
Q2 2019-0.8%-5.5%+5.6%
Q1 2019+4.7%+18.7%+0.9%
Q4 2018-3.6%-11.6%-22.5%
Q3 2018+7.8%+3.4%+2.7%
Q2 2018-30.9%-26.0%-14.7%
Q1 2018-16.7%-11.0%-4.3%
Q4 2017-18.8%-13.6%-15.8%
Q3 2017-9.6%-13.8%-2.6%
Q2 2017+3.1%+1.2%+2.5%
Q1 2017-13.0%-15.1%-16.7%
Q4 2016+3.4%-5.3%-7.2%
Q3 2016+22.9%+24.3%+31.7%
Q2 2016-11.5%-17.0%-14.2%
Q1 2016+10.0%
Q4 2015-21.9%
Q3 2015+9.5%
Q2 2015+10.1%
Q1 2015-4.6%
Q4 2014-9.6%
Q3 2014-0.5%
Q2 2014+1.8%
Q1 2014-14.3%
Q4 2013-22.3%
Q3 2013+3.1%
Q2 2013-3.3%
Q1 2013+0.4%
Q4 2009-5.5%
Q3 2012-0.9%
Q2 2012-5.5%
Q1 2011-3.1%
Q1 2012+11.8%
Q4 2011+0.8%
Q3 2010+2.5%
Q3 2011+2.5%
Q2 2011-33.6%
Q4 2010-33.6%
Q2 2010-33.6%
Q1 2010-7.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro